Insmed IncorporatedINSMNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank44
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P44
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -22.54% |
| Q3 2025 | -32.36% |
| Q2 2025 | 1104.13% |
| Q1 2025 | -65.61% |
| Q4 2024 | -42.71% |
| Q3 2024 | 1009.00% |
| Q2 2024 | 108.01% |
| Q1 2024 | -36.59% |
| Q4 2023 | -13.20% |
| Q3 2023 | -78.84% |
| Q2 2023 | -245.75% |
| Q1 2023 | -149.41% |
| Q4 2022 | 366.19% |
| Q3 2022 | -167.29% |
| Q2 2022 | -63.49% |
| Q1 2022 | -70.74% |
| Q4 2021 | -19.66% |
| Q3 2021 | -11.03% |
| Q2 2021 | 147.48% |
| Q1 2021 | -27.39% |
| Q4 2020 | -23.68% |
| Q3 2020 | -15.75% |
| Q2 2020 | 81.98% |
| Q1 2020 | -21.31% |
| Q4 2019 | -14.03% |
| Q3 2019 | -21.83% |
| Q2 2019 | 133.59% |
| Q1 2019 | -31.03% |
| Q4 2018 | -28.54% |
| Q3 2018 | -21.92% |
| Q2 2018 | -14.56% |
| Q1 2018 | 20.40% |
| Q4 2017 | -26.93% |
| Q3 2017 | 379.63% |
| Q2 2017 | -31.43% |
| Q1 2017 | -21.72% |
| Q4 2016 | -28.82% |
| Q3 2016 | -13.06% |
| Q2 2016 | -11.32% |
| Q1 2016 | -10.23% |